Educational research grant for Australian Boceprevir CUPIC Study evaluating safety outcomes in patients with chronic Hepatitis C Genotype 1 receiving Boceprevir based triple therapy

Project: Research

Project Details

StatusFinished
Effective start/end date31/05/1330/04/14

Funding

  • MSD (Merck Sharp & Dohme Australia) : AUD90,000.00